Pediatric Primary Care Case Studies (157 page)

Shigella
,
388

short acting beta
₂
-agonists.
See
SABAs (short acting beta
₂
-agonists)

short stature,
507
–518

case presentation for,
507
–508,
511
–512,
514
–515

diagnosis of,
507
–512

diagnostic testing,
511

differential,
508
–511,
510
t–511t

epidemiology/etiology,
509

history-taking,
507
–508

physical examination,
508
–509

Turner syndrome,
509
–516,
510
t–511t

fundamental contexts for,
507
–508,
516

management of,
512
–516

AAP guidelines,
512

cardiovascular issues,
512
–513

endocrine issues,
513

follow-up visits,
515
–516

genetic issues,
514

neurocognitive issues,
513

NIH guidelines,
512

psychosocial support,
513
–514

referrals,
514
–515

Turner Syndrome Consensus Study Group guidelines,
512

objectives for,
507

resources for,
516
–517

skin barrier dysfunction,
457

sleep patterns (infants),
163
–175

case presentation for,
163
–166,
169
–172

cultural/ethnic aspects of,
167

diagnosis of,
164
–165,
168

developmental issues,
166

history-taking,
164

normal sleep physiology,
165
–166

trained night feeders,
166

physical examinations,
166
–167

epidemiology/etiology of,
163
–166

fundamental contexts of,
163
,
172

management of,
168
–172

Ferber method,
169
–170

follow-up visits,
171
–172

routine establishment,
170
–171

separation anxiety,
170
–171

therapeutic plans,
168
–171,
169
b

objectives for,
163

resources for,
172
–173

SNAP (safety net antibiotic prescription),
353

SNOUT mnemonic,
241
t

social/language delays (toddlers),
27
–42

ASDs,
28
–40,
29
t,
30
f

AAP screen recommendations for,
27
–28,
35
,
39

ABA and,
37
–38

AD,
28
,
30
f

AS,
28

CARS and,
37

CHAT and,
35

diagnosis of,
33
–35,
34
b

diagnostic testing for,
35
–37,
36
f

DSM-IV-TR
criteria for,
30
f

epidemiology/etiology of,
29
,
31

history-taking for,
31
–32

M-CHAT and,
35
,
36
f

management of,
37
–39

PDD-NOS,
28

PDDST-II and,
35

physical examinations for,
33

plans, intervention,
37
–38

prognosis for,
39

TEACCH and,
37
–38

case presentation for,
27
–28

developmental milestones and,
28
,
29
t

fundamental contexts of,
27
–28,
39

objectives for,
27

plans for

diagnostic,
37

educational,
37
–39

intervention,
37
–38

resources for,
40
–41,
40
b

specificity vs., sensitivity,
240
–242

spermicides,
433

SPIN mnemonic,
241
t

sports examinations (adolescents),
133
–163

case presentation for,
134
,
140
–142,
145
,
157
–158

clearance,
137
t–139t,
158

diagnosis of,
151

follow-up visits for,
158

forms for,
135
f–136f

fundamental contexts of,
133
,
158
–159

history-taking for,
141
–142

management of,
152
–158,
152
t,
154
t–155t

concussion,
152
t

family planning/lifestyle issues,
158

female athlete triad,
143
–144,
157

fractures,
144
–145

general,
153
,
154
t–156t,
157

medroxyprogesterone (Depo-Provera),
145

musculoskeletal disorders,
144
–145

postconcussive syndrome,
142
–143

second-impact syndrome,
158

objectives for,
133

physical examinations for,
145
–151

diagnostic testing,
145
,
151

features of,
150
t

musculoskeletal,
145
–149,
146
f–149f